A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants
Completed · Phase 1
Conditions studied: Healthy Volunteer
In brief
The primary objective of the study is to evaluate the effects of a proton pump inhibitor (PPI) \[rabeprazole\] on BIIB122 pharmacokinetics (PK) after a single dose in healthy participants. The secondary objective of the study is to evaluate the safety and tolerability of BIIB122, with and without a PPI (rabeprazole), after a single dose in healthy participants.
Key facts
- Study ID
- NCT06264440
- Run by
- Biogen
- People needed
- 18
- Starts
- 2024-02-12
- Expected to finish
- 2024-06-18
- Last updated by the study team
- 2024-07-19
Who can join
Age: 30 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- PPD Development, LP — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.